在急性髓性白血病中抑制男性蛋白:病理生物学,进展和承诺
1Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL 33612, USA.
Biomedicines
|January 28, 2026
概括
梅宁抑制剂在治疗由KMT2A和NPM1.1等特定基因突变驱动的急性髓性白血病 (AML) 方面表现有前途. 这些向疗法正在改变AML治疗的复发,耐火和新诊断的患者.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 急性骨髓性白血病 (AML) 是一种多样化且具有攻击性的癌症.
- 一个重要的AML子集是由HOXA9和MEIS1瘤转录因子的过度表达驱动的.
- 关键的遗传异常包括KMT2A重组,NPM1突变和NUP98重组.
研究的目的:
- 审查KMT2A,NPM1和HOX/MEIS1途径在白血病发生中的生物学.
- 阐明脚手架蛋白质在表观遗传调节和恶性转变中的作用.
- 评估在AML中使用阴膜抑制剂的临床疗效和安全性.
主要方法:
- 关于KMT2A,NPM1,HOX/MEIS1通道以及 menin 的作用的当前文献的综述.
- 对单独治疗和组合治疗中的脑膜抑制剂的数据分析.
- 评估临床试验数据,包括疗效和安全性概况.
主要成果:
- 门因在表观遗传调节中发挥着中心作用,在特定的AML子集中驱动白血病发生.
- 门因抑制剂对KMT2A,NPM1或其他相关遗传异常的AML具有显著的治疗潜力.
- 新兴的临床数据显示了脑膜抑制剂的有希望的疗效和安全性.
结论:
- 梅宁抑制剂正在迅速成为AML复发/耐药性AML的关键治疗选择.
- 这些向性药物预计将在新诊断的AML治疗模式中发挥重要作用.
- 脑膜抑制剂的开发代表了AML精准医学的重大进步.
关键词:
在AML,AML就是AML.在KMT2A中.在 NPM1 中,在 NUP98 里面,你会看到 NUP98.急性骨髓性白血病 (AML) 是一种急性骨髓性白血病.在我看来,这是一件非常有趣的事情.更多相关视频
06:33Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
1.8K
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.7K
相关概念视频
Feedback Inhibition
57.1K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.1K
Tumor Progression
7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
Enzyme Inhibition
92.1K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.1K
Inhibition of Cdk Activity
6.0K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
mTOR Signaling and Cancer Progression
4.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.7K
Differentiation of Common Myeloid Progenitor Cells
4.0K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.0K
